Ingredia files structure function claims for blood sugar ingredient

Published: 1-Apr-2022

With 88 million of prediabetics estimated by the CDC, of which 80% will turn diabetic within 5 to 10 years if nothing is done, the prevention of diabetes is a strong concern in the US

Ingredia has launched Pep2Dia, an inhibitor of the alpha-glucosidase enzyme designed to help with the reduction of post-meal glycemia peak, and consequently with maintaining healthy blood sugar levels.

Following a NDI status obtained in February, Ingredia has notified to FDA two structure function claims for the ingredient:

  • Helps to maintain healthy blood sugar levels after meals
  • Helps to support healthy blood sugar levels

With 88 million of prediabetics estimated by the CDC, of which 80% will turn diabetic within 5 to 10 years if nothing is done, the prevention of diabetes is a strong concern in the US.

Reaching this stage of worrying blood sugar levels can happen quite easily after 40 years old, Ingredia says, especially with a family history of diabetes, obesity, a lack of physical activity and/or an unbalanced diet challenging your pancreas function.

You may also like